Erectile Dysfunction Drugs Market to Witness Robust Growth Driven by Increasing Geriatric Population
The global erectile dysfunction (ED) drugs market is poised for significant growth in the coming years, with projections indicating an expansion at a compound annual growth rate (CAGR) of 8.9%. The market, valued at US$2.8 billion in 2024, is expected to reach US$4.8 billion by 2030, reflecting the increasing prevalence of erectile dysfunction and the growing adoption of effective pharmaceutical treatments.
Comments
0 comment